PROACT is a Prospective Master Protocol for a Cohort Study Focused on Evaluating the Implementation of Integrated Proactive Supportive Care Pathways at Gustave Roussy

Launched by GUSTAVE ROUSSY, CANCER CAMPUS, GRAND PARIS · Jun 26, 2024

Keywords

ClinConnect Summary

The PROACT trial is studying how well a new supportive care program helps patients with cancer. This program aims to provide integrated, proactive support to improve the quality of care and reduce patient distress. The main goal is to see if this supportive care pathway makes a difference in how patients feel after 12 weeks of receiving help. Anyone who has been diagnosed with any type of cancer and is 18 years or older can participate, as long as they can understand and speak French and agree to join the study.

If you decide to take part in the PROACT trial, you'll receive a thorough assessment to identify your supportive care needs. Throughout the study, your feelings about distress will be tracked using a simple tool called the NCCN Distress Thermometer. This research is important because it could lead to better support for cancer patients, helping them manage their symptoms and improve their overall well-being.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Histological confirmation of cancer (any cancer type, any stage)
• • Age ≥ 18 years old
• • Received an integrated supportive care need assessment.
• • Sign the consent form for the PROACT study.
• Exclusion Criteria:
• • Absence or inability of written consent from the patient.
• • Does not understand or speak French.